The global cell culture media market was valued at USD 2.56 billion in 2023 and is expected to grow to USD 2.75 billion in 2024, reaching USD 7.45 billion by 2032, with a compound annual growth rate (CAGR) of 13.3% during the forecast period from 2024 to 2032. North America led the global market in 2023, holding a dominant share of 43.75%.
The global cell culture media market is witnessing significant growth, driven by technological advancements, increasing biopharmaceutical production, and the rising demand for cell-based therapies. This report provides key insights into the market's development, drivers, competitive landscape, and future scope.
Read More : https://www.fortunebusinessinsights.com/cell-culture-media-market-103333
One of the notable advancements in the cell culture media market occurred in July 2023 when Lonza launched its new cell culture platform, TheraPro CHO media system. Designed to work seamlessly with GS-CHO cell lines, the platform simplifies media preparation processes and enhances productivity. Such innovations are expected to contribute to the market's upward trajectory.
Leading players in the cell culture media market are continuously innovating to maintain a competitive edge. The top companies include: